Beyond CDR-grafting: Structure-guided humanization of framework and CDR regions of an anti-myostatin antibody
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Beyond CDR-grafting: Structure-guided humanization of framework and CDR regions of an anti-myostatin antibody
Authors
Keywords
-
Journal
mAbs
Volume 8, Issue 7, Pages 1302-1318
Publisher
Informa UK Limited
Online
2016-09-14
DOI
10.1080/19420862.2016.1215786
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Therapeutic Antibody Engineering To Improve Viscosity and Phase Separation Guided by Crystal Structure
- (2016) Chi-Kin Chow et al. MOLECULAR PHARMACEUTICS
- Antibody humanization by structure-based computational protein design
- (2015) Yoonjoo Choi et al. mAbs
- A Web Resource for Standardized Benchmark Datasets, Metrics, and Rosetta Protocols for Macromolecular Modeling and Design
- (2015) Shane Ó Conchúir et al. PLoS One
- Augmented Binary Substitution: Single-pass CDR germ-lining and stabilization of therapeutic antibodies
- (2015) Sue Townsend et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- AB-Bind: Antibody binding mutational database for computational affinity predictions
- (2015) Sarah Sirin et al. PROTEIN SCIENCE
- The therapeutic monoclonal antibody market
- (2014) Dawn M Ecker et al. mAbs
- Structure-Based Prediction of Asparagine and Aspartate Degradation Sites in Antibody Variable Regions
- (2014) Jasmin F. Sydow et al. PLoS One
- In silico selection of therapeutic antibodies for development: Viscosity, clearance, and chemical stability
- (2014) Vikas K. Sharma et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Monoclonal antibody humanness score and its applications
- (2013) Sean H Gao et al. BMC BIOTECHNOLOGY
- T-cell dependent immunogenicity of protein therapeutics: Preclinical assessment and mitigation
- (2013) Vibha Jawa et al. CLINICAL IMMUNOLOGY
- Humanization of Antibodies Using Heavy Chain Complementarity-determining Region 3 Grafting Coupled within VitroSomatic Hypermutation
- (2013) Peter M. Bowers et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Computational Prediction of Protein Hot Spot Residues
- (2012) John Kenneth Morrow et al. CURRENT PHARMACEUTICAL DESIGN
- Specificity and Structure of a High Affinity Activin Receptor-like Kinase 1 (ALK1) Signaling Complex
- (2012) Sharon A. Townson et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Myostatin as a therapeutic target in Amyotrophic Lateral Sclerosis
- (2012) Frank S. Walsh et al. NEUROCHEMISTRY INTERNATIONAL
- Structure of Myostatin·Follistatin-like 3
- (2011) Jennifer N. Cash et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- High-throughput measurement, correlation analysis, and machine-learning predictions for pH and thermal stabilities of Pfizer-generated antibodies
- (2011) Amy C. King et al. PROTEIN SCIENCE
- Features and development ofCoot
- (2010) P. Emsley et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- BMP-7 as antagonist of organ fibrosis
- (2010) Ralf Weiskirchen Frontiers in Bioscience-Landmark
- Characterization of the Ligand Binding Functionality of the Extracellular Domain of Activin Receptor Type IIB
- (2010) Dianne Sako et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Predictive tools for stabilization of therapeutic proteins
- (2010) Vladimir Voynov et al. mAbs
- The immunogenicity of humanized and fully human antibodies
- (2010) Fiona A. Harding et al. mAbs
- Reducing risk, improving outcomes: Bioengineering less immunogenic protein therapeutics
- (2009) Anne S. De Groot et al. CLINICAL IMMUNOLOGY
- The structure of myostatin:follistatin 288: insights into receptor utilization and heparin binding
- (2009) Jennifer N Cash et al. EMBO JOURNAL
- Crystal structure analysis reveals a spring-loaded latch as molecular mechanism for GDF-5–type I receptor specificity
- (2009) Alexander Kotzsch et al. EMBO JOURNAL
- Bone Morphogenetic Protein (BMP) and Activin Type II Receptors Balance BMP9 Signals Mediated by Activin Receptor-like Kinase-1 in Human Pulmonary Artery Endothelial Cells
- (2009) Paul D. Upton et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Stabilization and humanization of a single-chain Fv antibody fragment specific for human lymphocyte antigen CD19 by designed point mutations and CDR-grafting onto a human framework
- (2009) Markus Kügler et al. PROTEIN ENGINEERING DESIGN & SELECTION
- The influence of the framework core residues on the biophysical properties of immunoglobulin heavy chain variable domains
- (2009) Annemarie Honegger et al. PROTEIN ENGINEERING DESIGN & SELECTION
- A phase I/IItrial of MYO-029 in adult subjects with muscular dystrophy
- (2008) Kathryn R. Wagner et al. ANNALS OF NEUROLOGY
- Role of transforming growth factor-β superfamily signaling pathways in human disease
- (2008) Kelly J. Gordon et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Myostatin as a therapeutic target for musculoskeletal disease
- (2008) L. Bradley et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Fully human antibodies from transgenic mouse and phage display platforms
- (2008) Nils Lonberg CURRENT OPINION IN IMMUNOLOGY
- An Engineered Human Antibody Fab Fragment Specific for Pseudomonas aeruginosa PcrV Antigen Has Potent Antibacterial Activity
- (2008) M. Baer et al. INFECTION AND IMMUNITY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started